Unicycive Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]

Warrant Liability (Details) - USD ($) $ in Millions		6 Months Ended	12 Months Ended
Warrant Liability (Details) - USD ($) $ in Millions	Mar. 03, 2023	Jun. 30, 2025	Dec. 31, 2024	Jul. 11, 2023
Warrant Liability [Line Items]
Fair value of warrants	$ 2.8	$ 10.2	$ 18.9
Tranche A Warrant [Member] \| Series A-3 Preferred Stock [Member]
Warrant Liability [Line Items]
Acquired warrant shares	4,667,594			4,785,243
Tranche B Warrant [Member] \| Series A-4 Preferred Stock [Member]
Warrant Liability [Line Items]
Acquired warrant shares	4,243,267			4,350,221
Tranche C Warrant [Member] \| Series A-5 Preferred Stock [Member]
Warrant Liability [Line Items]
Acquired warrant shares	6,789,228			6,960,353